The EMA’s CHMP has recommended marketing authorisation for two obicetrapib [...]
Chiesi Global Rare Diseases has received a positive CHMP opinion [...]
The EMA’s CHMP has recommended marketing authorisation for two obicetrapib [...]
Chiesi Global Rare Diseases has received a positive CHMP opinion [...]